Fecal Incontinence Clinical Trial
Official title:
Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor - An Observational Single Center Study on Patients Suffering From Fecal Incontinence.
NCT number | NCT02778048 |
Other study ID # | KEK BE 359/15 |
Secondary ID | |
Status | Suspended |
Phase | |
First received | |
Last updated | |
Start date | July 2019 |
Est. completion date | December 2020 |
Verified date | January 2019 |
Source | University Hospital Inselspital, Berne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
With the project Smart Muscle for Incontinence Treatment (SMIT) a multidisciplinary
consortium consisting of representatives ranging from clinical medicine via microelectronics
towards biomaterial science aims to develop a novel implant to treat faecal incontinence. The
aim of this campaign includes development of implantable prototype devices acting as
artificial continence muscles using low-voltage electrically activated polymers (EAPs)
controlled by implemented pressure sensors and the patient.
Subsequently, the knowledge of the anatomical and biomechanical properties of the anal
sphincter complex are of cardinal importance. Most of the existing data on anatomy and
physiology results is based on old studies and almost no data on biomechanical properties are
available. However, new technologies or even merging data from different examination methods
might provide new information in this field.
Status | Suspended |
Enrollment | 50 |
Est. completion date | December 2020 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - Informed Consent as documented by signature - Wexner score >= 12 - Longo's obstructed defecation syndrome (ODS) score =0 - MRI safety (no metallic implants. Appendix MRI safety form) - Normal weighted (20<BMI<30) - Age = 60 years Exclusion Criteria: - Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) - Known or suspected non-compliance, drug or alcohol abuse - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Bern | Bern |
Lead Sponsor | Collaborator |
---|---|
University Hospital Inselspital, Berne | Kantonsspital Winterthur KSW, Nano-Tera.ch, Lausanne, University of Basel, University of Bern |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | sphincter closing pressure [mmHG] | at rest and during squeeze manoeuvres | 1 year | |
Primary | sphincter muscle length [mm] | 1 year | ||
Primary | sphincter muscle thickness [mm] | 1 year | ||
Primary | sphincter compliance [mm/mmHG] | The compliance is a measure used in medicine describing the elasticity of tissue. In the case of this study it describes the elasticity of the anal canal, the sphincter muscles respectively. The compliance is directly measured with the help of the functional lumen imaging probe (FLIP). | 1 year | |
Secondary | Young's modulus of sphincter muscle (mmHG/mm2] | combination of compliance and anatomical properties | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03825575 -
Sacral Neuromodulation as Treatment for Fecal Incontinence
|
N/A | |
Completed |
NCT00605826 -
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
|
N/A | |
Withdrawn |
NCT02208258 -
Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.
|
N/A | |
Completed |
NCT01957969 -
French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence
|
N/A | |
Completed |
NCT01939821 -
A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Recruiting |
NCT00530933 -
Tibial Nerve Stimulation for Faecal Incontinence
|
N/A | |
Withdrawn |
NCT00522691 -
Efficacy of Sacral Nerve Stimulation Before Definitive Implantation
|
N/A | |
Completed |
NCT00565136 -
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT00677508 -
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
|
||
Completed |
NCT05032534 -
Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence
|
N/A | |
Completed |
NCT05058326 -
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
|
||
Completed |
NCT03746834 -
NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation
|
Phase 4 | |
Completed |
NCT00124904 -
Biofeedback for Fecal Incontinence
|
N/A | |
Completed |
NCT03028636 -
LIBERATE - PRO: Eclipseâ„¢ System Registry
|
||
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 | |
Completed |
NCT05621629 -
Management of FI After Surgery of ARM
|
||
Withdrawn |
NCT04138602 -
BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence
|
N/A | |
Completed |
NCT04478799 -
Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience
|
N/A | |
Completed |
NCT03252951 -
Physical Therapy for Anal Incontinence
|
N/A |